Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation.
Front Oncol. 2022 Jul 27;12:931774. doi: 10.3389/fonc.2022.931774. eCollection 2022.
Front Oncol. 2022.
PMID: 35965494
Free PMC article.
Review.
Tyrosine phosphatase PTPN11/SHP2 in solid tumors - bull's eye for targeted therapy?
Chen X, Keller SJ, Hafner P, Alrawashdeh AY, Avery TY, Norona J, Zhou J, Ruess DA.
Chen X, et al. Among authors: avery ty.
Front Immunol. 2024 Mar 5;15:1340726. doi: 10.3389/fimmu.2024.1340726. eCollection 2024.
Front Immunol. 2024.
PMID: 38504984
Free PMC article.
Review.
Item in Clipboard
Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness.
Avery TY, Bons J, van Paassen P, Damoiseaux J.
Avery TY, et al.
Lupus. 2016 Jul;25(8):917-24. doi: 10.1177/0961203316640921.
Lupus. 2016.
PMID: 27252270
Item in Clipboard
Anti-nuclear antibodies in daily clinical practice: prevalence in primary, secondary, and tertiary care.
Avery TY, van de Cruys M, Austen J, Stals F, Damoiseaux JG.
Avery TY, et al.
J Immunol Res. 2014;2014:401739. doi: 10.1155/2014/401739. Epub 2014 Mar 13.
J Immunol Res. 2014.
PMID: 24741596
Free PMC article.
Item in Clipboard
Cite
Cite